Tower Research Capital (TRC)’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.5K | Buy |
8,773
+4,884
| +126% | +$54.8K | ﹤0.01% | 2389 |
|
|
2025
Q1 | $17.8K | Sell |
3,889
-9,508
| -71% | -$43.5K | ﹤0.01% | 3091 |
|
|
2024
Q4 | $75.6K | Sell |
13,397
-12,890
| -49% | -$72.7K | ﹤0.01% | 2319 |
|
|
2024
Q3 | $127K | Buy |
26,287
+1,525
| +6% | +$7.38K | ﹤0.01% | 2039 |
|
|
2024
Q2 | $121K | Buy |
24,762
+23,521
| +1,895% | +$115K | ﹤0.01% | 2446 |
|
|
2024
Q1 | $16.5K | Sell |
1,241
-148
| -11% | -$1.97K | ﹤0.01% | 3177 |
|
|
2023
Q4 | $19.4K | Sell |
1,389
-732
| -35% | -$10.2K | ﹤0.01% | 3668 |
|
|
2023
Q3 | $28.1K | Sell |
2,121
-1,428
| -40% | -$18.9K | ﹤0.01% | 3069 |
|
|
2023
Q2 | $66.5K | Sell |
3,549
-2,784
| -44% | -$52.2K | ﹤0.01% | 2325 |
|
|
2023
Q1 | $91K | Buy |
6,333
+359
| +6% | +$5.16K | ﹤0.01% | 1960 |
|
|
2022
Q4 | $116K | Sell |
5,974
-165
| -3% | -$3.2K | ﹤0.01% | 1723 |
|
|
2022
Q3 | $211K | Buy |
6,139
+3,815
| +164% | +$131K | ﹤0.01% | 1879 |
|
|
2022
Q2 | $35K | Sell |
2,324
-1,500
| -39% | -$22.6K | ﹤0.01% | 3225 |
|
|
2022
Q1 | $87K | Sell |
3,824
-2,025
| -35% | -$46.1K | ﹤0.01% | 2319 |
|
|
2021
Q4 | $216K | Buy |
5,849
+4,749
| +432% | +$175K | ﹤0.01% | 1707 |
|
|
2021
Q3 | $52K | Buy |
+1,100
| New | +$52K | ﹤0.01% | 2938 |
|